Scripps 5th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2022 (Videos)

Advanced Cardiomyopathy, Heart Failure & Cardio-Oncology Update

The Scripps 5th Annual Cardiomyopathy and Cardio-Oncology Symposium 2022 is a comprehensive, state-of-the-art educational program focused on the diagnosis, treatment, and long-term management of cardiomyopathies and cardiovascular complications associated with cancer therapies. Through expert-led, case-based discussions, this symposium provides clinicians with practical strategies for managing complex cardiovascular conditions in both heart failure and oncology patients.

As advances in cancer treatment continue to improve survival rates, cardiovascular disease has emerged as a major cause of morbidity and mortality among cancer survivors. Simultaneously, significant developments in the understanding and treatment of cardiomyopathies—including cardiac amyloidosis, hypertrophic cardiomyopathy, and inherited cardiomyopathies—have transformed clinical practice. This symposium brings together nationally recognized experts in cardiology and oncology to review the latest evidence, clinical guidelines, diagnostic approaches, and emerging therapies.

Product Details

Format: 18 Videos
File Size: 1.87 GB
Year: 2022
Language: English

Target Audience

• Cardiologists
• Oncologists
• Heart Failure Specialists
• Cardio-Oncology Specialists
• Internal Medicine Physicians
• Hematologists
• Advanced Practice Providers
• Cardiology Fellows
• Oncology Fellows
• Nurses and Allied Healthcare Professionals

Course Overview

The Scripps Cardiomyopathy and Cardio-Oncology Symposium 2022 delivers a practical and evidence-based review of contemporary cardiomyopathy management and cardiovascular care in cancer patients and survivors. Faculty utilize real-world clinical cases to highlight diagnostic challenges, treatment decisions, multidisciplinary collaboration, and emerging therapies.

Special emphasis is placed on cardiovascular toxicities associated with chemotherapy, immunotherapy, targeted cancer treatments, and radiation therapy. Participants also explore advances in the diagnosis and management of heart failure, cardiac amyloidosis, genetic cardiomyopathies, and arrhythmia-related cardiomyopathies.

The ultimate goal is to equip clinicians with the latest knowledge and practical tools needed to improve outcomes for patients with cardiovascular disease and cancer-related cardiac complications.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Apply contemporary evidence-based approaches to cardiomyopathy management
• Recognize and manage cardiovascular toxicities associated with cancer therapies
• Evaluate patients with cardiac amyloidosis using modern diagnostic techniques
• Identify inherited and genetic cardiomyopathies and understand appropriate testing strategies
• Assess and manage heart failure in complex cardiovascular patients
• Utilize advanced imaging techniques for cardiomyopathy diagnosis
• Develop multidisciplinary management plans for cardio-oncology patients
• Recognize arrhythmias associated with cardiomyopathies and cancer therapies
• Improve long-term cardiovascular outcomes among cancer survivors

Major Topics Covered

❤️ Cardiomyopathy Management

Comprehensive Review of:

• Dilated Cardiomyopathy
• Hypertrophic Cardiomyopathy (HCM)
• Restrictive Cardiomyopathy
• Infiltrative Cardiomyopathies
• Genetic Cardiomyopathies
• Arrhythmogenic Cardiomyopathy

Clinical Focus

• Early Diagnosis
• Risk Stratification
• Advanced Therapies
• Long-Term Follow-Up

Cardiac Amyloidosis

Emerging Diagnostic and Therapeutic Advances

Topics Include

• Transthyretin Amyloidosis (ATTR)
• Light Chain (AL) Amyloidosis
• Imaging-Based Diagnosis
• Nuclear Imaging Techniques
• Cardiac MRI Applications
• Novel Disease-Modifying Therapies

Clinical Updates

• Tafamidis and Emerging Treatments
• Screening Strategies
• Multidisciplinary Care Models

Heart Failure

Contemporary Management Approaches

Topics Covered

• Heart Failure with Reduced Ejection Fraction (HFrEF)
• Heart Failure with Preserved Ejection Fraction (HFpEF)
• Diastolic Dysfunction
• Advanced Heart Failure
• Guideline-Directed Medical Therapy (GDMT)

New Therapies

• SGLT2 Inhibitors
• ARNI Therapy
• Novel Heart Failure Medications
• Device-Based Therapies

Cardio-Oncology

Cardiovascular Care of Cancer Patients

Topics Include

• Cardiotoxicity Risk Assessment
• Chemotherapy-Induced Cardiomyopathy
• Radiation-Induced Heart Disease
• Immunotherapy-Related Cardiac Toxicity
• Targeted Therapy Cardiovascular Effects

Clinical Focus

• Prevention Strategies
• Early Detection
• Monitoring Protocols
• Long-Term Management

Cancer Survivor Cardiovascular Health

Long-Term Follow-Up Care

Topics Covered

• Survivorship Programs
• Cardiovascular Risk Assessment
• Late Effects of Cancer Treatment
• Preventive Cardiology in Cancer Survivors

Key Areas

• Coronary Disease Risk
• Heart Failure Prevention
• Vascular Complications
• Lifestyle Interventions

Advanced Cardiovascular Imaging

Imaging for Cardiomyopathy and Cardio-Oncology

Modalities Reviewed

• Echocardiography
• Global Longitudinal Strain Imaging
• Cardiac MRI
• Nuclear Imaging
• Cardiac CT

Clinical Applications

• Early Detection of Cardiotoxicity
• Amyloidosis Diagnosis
• Myocardial Tissue Characterization
• Risk Stratification

Genetic Cardiomyopathies

Precision Medicine in Cardiovascular Care

Topics Include

• Genetic Testing
• Family Screening
• Inherited Cardiomyopathy Syndromes
• Clinical Interpretation of Genetic Results

Clinical Importance

• Early Diagnosis
• Family Counseling
• Personalized Treatment Strategies

Arrhythmias and Cardiomyopathy

Electrical Complications of Structural Heart Disease

Topics Covered

• Atrial Fibrillation
• Ventricular Arrhythmias
• Sudden Cardiac Death Risk Assessment
• ICD Therapy
• Catheter Ablation Strategies

Case-Based Learning

A hallmark of the symposium is its practical, patient-centered educational approach.

Real-World Clinical Cases

Participants review:

• Challenging Cardiomyopathy Cases
• Cardio-Oncology Management Scenarios
• Advanced Heart Failure Patients
• Amyloidosis Diagnostic Workups
• Arrhythmia Management Strategies

Interactive Discussions

• Diagnostic Decision-Making
• Treatment Selection
• Multidisciplinary Collaboration
• Guideline Implementation

Educational Highlights

Nationally Recognized Faculty

Learn from experts in:

• Heart Failure
• Cardiomyopathy
• Cardio-Oncology
• Cardiac Imaging
• Electrophysiology
• Preventive Cardiology

Evidence-Based Updates

Review the latest:

• Clinical Trials
• Treatment Guidelines
• Emerging Therapies
• Diagnostic Technologies

Practical Clinical Application

Strategies and recommendations designed for immediate implementation in clinical practice.

Why This Course Is Valuable

✔ Comprehensive Cardiomyopathy Review

✔ Advanced Cardio-Oncology Education

✔ Cardiac Amyloidosis Updates

✔ Heart Failure Management Strategies

✔ Genetic Cardiomyopathy Evaluation

✔ Imaging-Based Diagnosis

✔ Cancer Therapy Cardiotoxicity Monitoring

✔ Arrhythmia and Sudden Death Risk Assessment

✔ Case-Based Learning Format

✔ Evidence-Based Clinical Updates

✔ Multidisciplinary Care Approach

✔ Practical Patient Management Guidance

Who Should Study This Program?

Ideal for:

• Cardiologists
• Oncologists
• Heart Failure Specialists
• Cardio-Oncology Clinicians
• Internal Medicine Physicians
• Hematologists
• Nurse Practitioners
• Physician Assistants
• Cardiology Fellows
• Oncology Fellows

Clinical & Educational Value

The Scripps 5th Annual Cardiomyopathy and Cardio-Oncology Symposium 2022 provides a highly practical and clinically relevant review of contemporary cardiomyopathy management and cardiovascular care for cancer patients and survivors. Through expert-led lectures and case-based discussions, participants gain the latest evidence-based knowledge needed to diagnose, monitor, and manage complex cardiovascular conditions while improving long-term patient outcomes.

+ Topics:

• Best Practices in Managing Cardiac Toxicity in the Breast Cancer Patient The Cardiologist’s Perspective-Margot Davis, MD, MSc.mp4
• Best Practices in Managing Cardiac Toxicity in the Breast Cancer Patient The Oncologist’s Perspective-Carrie Costantini, MD.mp4
• Cancer Survivorship How to Monitor for Cardiac Disease Following Treatment-Ann Kuo, MD.mp4
• Cardiac Sarcoidosis Making the Diagnosis, An Imaging Primer-Ajay Srivastava, MD.mp4
• Cardiac Sarcoidosis Who and How to Treat-Sumeet Mitter, MD.mp4
• Clinical Presentation of Cardiac Amyloid Who Should We Suspect-Rajeev Mohan, MD.mp4
• Contemporary Management of AL Amyloidosis-Anuj Mahindra, MD.mp4
• How to Make the Diagnosis of Cardiac Amyloid-Rola Khedraki, MD.mp4
• Managing End-Stage Heart Failure in the Cancer Survivor-Brian Hardaway, MD.mp4
• Managing Venous Thromboembolic Disease in the Cancer Patient-Scott Cameron, MD, PhD.mp4
• Multi-Modality Imaging in Cardio-Oncology-Ballaji Tamarappoo, MD, PhD.mp4
• Pharmacogenomics in Heart Failure-David Lanfear, MD, MS.mp4
• Q&A Panel Discussion-Carrie Costantini, MD, Margot Davis, MD, MSc, and Prabhakar Tripuraneni, MD.mp4
• Q&A Panel Discussion-David Lanfear, MD, MS, Sumeet Mitter, MD, and Julie Rosenthal, MD.mp4
• Strategies to Minimize Radiation-Induced Heart Disease-Prabhakar Tripuraneni, MD.mp4
• The Spectrum of Myocarditis From COVID to Immune Therapy-Nicolas Palaskas, MD.mp4
• Treatment of ATTR Amyloid Current Options-Julie Rosenthal, MD.mp4
• Treatment of ATTR Amyloid The Emerging Landscape-Ronald Witteles, MD.mp4